[SCHEDULE 13G/A] Translational Development Acquisition Corp. SEC Filing
Translational Development Acquisition Corp. disclosure shows a group tied to Wolverine holds 1,557,134 Class A ordinary shares, representing
Translational Development Acquisition Corp. disclose richiama che un gruppo legato a Wolverine detiene 1,557,134 azioni ordinarie di Classe A, rappresentando
Translational Development Acquisition Corp. la divulgación muestra un grupo vinculado a Wolverine que posee 1,557,134 acciones ordinarias de Clase A, que representan
Translational Development Acquisition Corp. 공개 자료에 따르면 Wolverine과 연관된 그룹이 1,557,134주의 A클래스 보통주를 보유하고 있으며, 이는 발행 A클래스 주식의
Translational Development Acquisition Corp. disclosure montre qu’un groupe lié à Wolverine détient 1 557 134 actions ordinaires de classe A, représentant
Translational Development Acquisition Corp. Offenlegung zeigt, dass eine Gruppe im Zusammenhang mit Wolverine 1.557.134 Class A Stammaktien hält, was
Translational Development Acquisition Corp. الكشف يظهر أن مجموعة مرتبطة بـ Wolverine تمتلك 1,557,134 سهماً عاديًا من الفئة A، ما يمثل
Translational Development Acquisition Corp. 的披露显示,与 Wolverine 相关的一组持有 1,557,134 股 A 类普通股,约占在外流通的 A 类股总数的
- Material disclosure of a
9.03% beneficial stake (1,557,134 shares) provides transparency to investors - Clear chain of control listed: Wolverine Asset Management, Wolverine Holdings, Wolverine Trading Partners, and named individuals
- Shared voting power only; no sole voting or dispositive power reported which may limit unilateral action
- Position size (>5%) can be market-moving if the shares are sold or increased, affecting liquidity
Insights
Large disclosed stake may affect shareholder dynamics.
The filing documents a
Dependencies include whether the position is passive as certified and any future Schedule 13D changes; monitor near-term filings for shifts in voting power or statements of intent within months.
Stake size and shared control are relevant for liquidity and block trading.
The position equals
Key near-term items to watch are additional amendments, transfer notices, or large transactions that would alter the
Translational Development Acquisition Corp. disclose richiama che un gruppo legato a Wolverine detiene 1,557,134 azioni ordinarie di Classe A, rappresentando
Translational Development Acquisition Corp. la divulgación muestra un grupo vinculado a Wolverine que posee 1,557,134 acciones ordinarias de Clase A, que representan
Translational Development Acquisition Corp. 공개 자료에 따르면 Wolverine과 연관된 그룹이 1,557,134주의 A클래스 보통주를 보유하고 있으며, 이는 발행 A클래스 주식의
Translational Development Acquisition Corp. disclosure montre qu’un groupe lié à Wolverine détient 1 557 134 actions ordinaires de classe A, représentant
Translational Development Acquisition Corp. Offenlegung zeigt, dass eine Gruppe im Zusammenhang mit Wolverine 1.557.134 Class A Stammaktien hält, was